Adam D. Cohen, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Adam D. Cohen, MD

Adam D. Cohen, MD

Healthcare Professional
Director
Myeloma Immunotherapy
Perelman Center for Advanced Medicine
West Pavilion, 4th Floor
3400 Civic Center Boulevard
Philadelphia, Pennsylvania, United States
Dr. Adam Cohen is the Director at Myeloma Immunotherapy and Associate Professor of Medicine in Hematology/Oncology Division at Abramson Cancer Center of the University of Pennsylvania, Philadelphia. He received his medical degree from the University of Pennsylvania, Philadelphia, where he also completed an internal medicine residency. He then completed a hematology/oncology fellowship, and worked as a research associate in the Laboratory of Tumor Immunology at Memorial Sloan-Kettering Cancer Center, New York. 
 
Dr. Cohen is board certified in internal medicine, medical oncology, and hematology.  His speciality includes hematology, medical oncology, autologous stem cell transplantation, al amyloidosis, multiple myeloma and Waldenstrom Macroglobulinemia (WM). His research expertise includes cancer immunotherapy, vaccines, cellular therapy, phase I trials and CAR T cells.
 
Dr. Adam Cohen is a member of the American Society of Clinical Oncology, American Association for Cancer Research, American Society for Blood and Marrow Transplantation, and the American Society of Hematology. He is also a member of the Multiple Myeloma Committee, Eastern Cooperative Oncology Group and previously served on the Multiple Myeloma Panel, National Comprehensive Cancer Network. 
 
 
Representative Publications:
 
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close